Squarepoint Ops LLC Intercept Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

  • $96.1 Billion
  • Q3 2025

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$11.61 - $16.11 $8,219 - $11,405
-708 Reduced 4.99%
13,492 $166,000
Q3 2022

Nov 14, 2022
SELL
$12.21 - $19.7 $836,983 - $1.35 Million
-68,549 Reduced 82.84%
14,200 $198,000
Q2 2022

Aug 15, 2022
BUY
$11.23 - $19.59 $470,997 - $821,624
41,941 Added 102.78%
82,749 $1.14 Million
Q1 2022

May 16, 2022
SELL
$13.37 - $17.79 $274,352 - $365,050
-20,520 Reduced 33.46%
40,808 $664,000
Q4 2021

Feb 14, 2022
SELL
$14.28 - $19.53 $88,193 - $120,617
-6,176 Reduced 9.15%
61,328 $999,000
Q3 2021

Nov 15, 2021
BUY
$12.99 - $20.47 $453,195 - $714,157
34,888 Added 106.97%
67,504 $1 Million
Q2 2021

Aug 16, 2021
SELL
$15.46 - $24.5 $551,705 - $874,307
-35,686 Reduced 52.25%
32,616 $651,000
Q1 2021

May 17, 2021
BUY
$19.33 - $37.75 $1.32 Million - $2.58 Million
68,302 New
68,302 $1.58 Million
Q4 2020

Feb 16, 2021
SELL
$24.48 - $42.47 $447,984 - $777,201
-18,300 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$39.09 - $53.44 $212,375 - $290,339
5,433 Added 42.22%
18,300 $759,000
Q2 2020

Aug 14, 2020
BUY
$46.7 - $92.04 $32,830 - $64,704
703 Added 5.78%
12,867 $616,000
Q1 2020

May 15, 2020
BUY
$48.35 - $118.68 $588,129 - $1.44 Million
12,164 New
12,164 $766,000
Q4 2019

Feb 14, 2020
SELL
$57.36 - $124.1 $1.03 Million - $2.23 Million
-17,979 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$58.69 - $80.46 $1.06 Million - $1.45 Million
17,979 New
17,979 $1.19 Million
Q1 2019

May 15, 2019
SELL
$91.83 - $120.68 $312,130 - $410,191
-3,399 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$85.79 - $126.46 $10,123 - $14,922
118 Added 3.6%
3,399 $343,000
Q3 2018

Nov 14, 2018
BUY
$88.49 - $127.55 $290,335 - $418,491
3,281 New
3,281 $415,000
Q1 2018

May 15, 2018
SELL
$52.72 - $67.25 $3.29 Million - $4.2 Million
-62,445 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$58.2 - $72.76 $3.63 Million - $4.54 Million
62,445
62,445 $3.65 Million

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email